Lisdexamfetamine Dimesylate · #29 of 35 active shortages by FDA posting duration
Brand: LISDEXAMFETAMINE DIMESYLATE
FDA lists Lisdexamfetamine Dimesylate as Active Shortage (Lannett Company, Inc.).
Availability on file: Available
Lisdexamfetamine Dimesylate Capsule: Active Shortage
Available 108 shortage presentations are tracked for this drug. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Lisdexamfetamine Dimesylate Capsule
- Manufacturer
- Lannett Company, Inc.
- Dosage Form
- Capsule
- Presentation
- Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0527-4663-37)
- Package NDC
- 0527-4663-37
Status & Timeline
- Status
- Active Shortage
- Availability
- Available
- First Reported
- Jul 14, 2023
- Last Updated
- Mar 16, 2026
- Therapeutic Category
- Psychiatry
Row fields from the FDA Drug Shortages database via openFDA.
Full Drug Profile
lisdexamfetamine
Side effects, interactions, warnings & more
Nearby, Other Lisdexamfetamine Shortage Records
Lisdexamfetamine Dimesylate Capsule
Rhodes Pharmaceuticals L.P.
Capsule
Lisdexamfetamine Dimesylate Capsule
Rhodes Pharmaceuticals L.P.
Capsule
Lisdexamfetamine Dimesylate Capsule
Rhodes Pharmaceuticals L.P.
Capsule
Lisdexamfetamine Dimesylate Capsule
Rhodes Pharmaceuticals L.P.
Capsule
Lisdexamfetamine Dimesylate Capsule
Rhodes Pharmaceuticals L.P.
Capsule
Lisdexamfetamine Dimesylate Capsule
Rhodes Pharmaceuticals L.P.
Capsule